The most recent guidelines of the European Association for the Study of the Liver indicate personalized erythrapheresis as the preferred treatment in selected patients with HC and clinical manifestations of iron overload and suggest regular blood donation for individuals with at risk genotypes and increased transferrin saturation, but with normal ferritin levels, particularly if identified in early adulthood (8). The gene discussed is TF; the disease is Tangier disease.